Finance

Beta
Lists
4980:TYO
Dexerials Corp
¥4,241.00
-5.82%
(-262.00) 1D
Jun 4, 11:30:00 AM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4980...
Open
¥4,495
High
¥4,525
Low
¥4,232
Mkt. cap
741.08B
Avg. vol.
2.86M
Volume
1.10M
Dividend
1.37%
Quarterly dividend
¥15
Ex-dividend date
Mar 30, 2026
P/E ratio
26.50
52-wk high
¥4,859
52-wk low
¥1,903
EPS
¥160
Shares outstanding
60.58M
No. of employees
2K
Open
¥4,495
High
¥4,525
Low
¥4,232
Mkt. cap
741.08B
Avg. vol.
2.86M
Volume
1.10M
Dividend
1.37%
Quarterly dividend
¥15
Ex-dividend date
Mar 30, 2026
P/E ratio
26.50
52-wk high
¥4,859
52-wk low
¥1,903
EPS
¥160
Shares outstanding
60.58M
No. of employees
2K
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to 4980 in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for 4980 in the last 3 months.
Highest
Current ¥4,241.00
¥2,650.00 (-37.51%)
Average
¥2,650.00 (-37.51%)
Lowest
¥2,650.00 (-37.51%)
News stories
From sources across the web
Profile
Sony Chemicals Corporation was a Japanese company established 1962, and was a wholly owned subsidiary of Sony Corporation. In 2008, Sony Chemical & Information Device transferred its thermal transfer ink ribbon business to Dai Nippon Printing. In 2012, Sony Chemicals Corporation was separated from Sony Group and renamed Dexerials Corporation. As of 2024, The Master Trust Bank of Japan, Ltd. is the largest shareholder of the corporation. Wikipedia
About Dexerials Corp
CEO-
Employees1.89K
Founded1962
Headquarters-
SectorComputer hardware
Last report
May 14, 2026
Fiscal period
Q4 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
26.54B / 24.95B
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
26.14B
31.32B
29.84B
26.54B
Cost of goods sold
12.37B
13.02B
12.31B
12.38B
Cost of revenue
12.37B
13.02B
12.31B
12.38B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.87B
6.05B
6.22B
6.27B
Operating expense
5.79B
6.38B
6.99B
6.51B
Total operating expenses
18.16B
19.40B
19.29B
18.89B
Operating income
7.98B
11.92B
10.55B
7.65B
Other non operating income
-1.00M
-
194.00M
-1.00M
EBT including unusual items
7.71B
12.08B
10.76B
7.83B
EBT excluding unusual items
7.71B
12.08B
10.76B
7.83B
Income tax expense
2.14B
4.24B
2.91B
1.09B
Effective tax rate
27.81%
35.08%
27.01%
13.90%
Other operating expenses
-85.00M
335.00M
770.00M
234.00M
Net income
5.56B
7.84B
7.86B
6.74B
Net profit margin
21.29%
25.05%
26.33%
25.41%
Earnings per share
-
-
-
-
Interest and investment income
8.00M
39.00M
7.00M
30.00M
Interest expense
-169.00M
-25.00M
-205.00M
-
Net interest expenses
-161.00M
14.00M
-198.00M
30.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
9.77B
13.72B
-
9.55B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more